Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
COMPLICATIONS OF POST-COVID PNEUMONIA IN CHILDREN
Professor
Ashurova Dilfuza Toshpulatovna
Akbarova Muruvat Sobirovna
Tashkent State Medical University
pediatric diseases propaedeutics department
Email:
Sherzodganiyevich518@gmail.com
ABSTRACT:
The COVID-19 pandemic has caused numerous health issues not only in
adults but also in children. This infection, especially, may lead to the development of
pneumonia, which severely affects children’s health. This article examines post-COVID
pneumonia and its complications in children. The article outlines the impact of pneumonia
on children’s bodies, its development process, clinical symptoms, analyses, and treatment
methods. Additionally, it provides information on the psychological and physical effects of
this disease on children.
Introduction
The COVID-19 pandemic put enormous pressure on health systems worldwide, and many
countries took strong measures to combat this infection. However, the impact of COVID-19
infection on children is still not fully understood, and its complications may lead to risks in
various areas. Pneumonia, especially in children, is one of the serious complications of
COVID-19 infection.
COVID-19 infection in children can cause acute respiratory problems. In some cases, the
infection leads to the development of pneumonia, which has long-term effects on children's
health. Research indicates that 5-10% of children infected with COVID-19 develop
pneumonia, a statistic that is linked not only to the severity of the infection but also to how
the child’s immune system responds.
Main Section
1. Development of Post-COVID Pneumonia
COVID-19 infection affects the lower parts of the respiratory system, leading to the
development of pneumonia. Pneumonia manifests as inflammation of the lung tissues. This
process typically leads to acute respiratory problems, which may result in oxygen deficiency
and shortness of breath.
Children's immune systems differ from adults, which can affect how the COVID-19
infection impacts their bodies. On the other hand, many children experience mild or non-
severe symptoms, but in some cases, the infection leads to pneumonia.
Main factors contributing to the development of pneumonia in children:
Weak immune system:
Some children are born with or develop weak immune
systems due to congenital factors or illnesses, which increases the risk of developing
pneumonia.
Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Age:
Children under the age of 5 may face greater challenges in combating COVID-
19 infection.
Living in large families:
In larger families, especially those with frequent social
interactions, children are at a higher risk of infection.
2. Complications of Pneumonia in Children
The spread of pneumonia among children can lead to numerous negative outcomes. The
complications may include:
Oxygen Deficiency:
In children with pneumonia, the damage to lung tissue leads to
oxygen deficiency. This condition often requires hospitalization.
Heart Disorders:
Inflammation of the lungs can affect the heart, potentially leading
to heart function disturbances.
Neurological Impact:
Pneumonia in children can lead to long-term psychological
complications. The infection may weaken certain parts of the brain, leading to neurological
issues among children.
3. Treatment Methods for Post-COVID Pneumonia
The treatment of post-COVID pneumonia in children involves the following medical
approaches:
Antibiotics and Antiviral Medications:
Antibiotics and antivirals are widely used
in treating pneumonia. These help reduce the inflammation caused by the infection and
promote faster recovery.
Oxygen Therapy:
When oxygen deficiency occurs in the lungs, oxygen therapy is
provided to support the child’s respiratory system and normalize oxygen levels.
Immunostimulants:
Immunostimulant drugs are used in treating pneumonia to
strengthen the immune system, improving the div’s ability to fight the infection.
4. Prevention and Risk Mitigation
To prevent the spread of COVID-19 and pneumonia in children, the following preventive
measures are recommended:
Vaccination:
Vaccination against COVID-19 in children helps prevent the
development of pneumonia.
Hygiene Practices:
Ensuring children wash their hands, face, and wear masks helps
prevent infection transmission.
Social Distancing:
Maintaining social distance among children reduces the spread of
infection.
Regular Medical Checkups:
Regularly monitoring children’s health and updating
vaccinations is important.
5. Psychological Impact of COVID-19 on Children
COVID-19 has had a profound psychological impact on children. Many children experience
anxiety, stress, and depression while fighting the infection and dealing with quarantine
measures. The negative psychological consequences include:
Vo
lu
m
e
5,
Ju
ly
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Anxiety:
Fear of illness, staying at home for long periods, and social isolation
increase anxiety in children.
Depression:
Long-term isolation and school closures may lead to the development
of psychological depression in children.
Reduced Physical Activity:
Children often reduce their physical activity while
staying at home, which negatively affects their health.
References:
1.
John, P. & Smith, A. (2022). COVID-19 and its impact on pediatric health: A global
perspective. Journal of Pediatric Medicine, 35(4), 301-310.
2.
Lee, S. (2021). Post-COVID pneumonia in children: Risks and interventions.
Pediatric Infectious Disease Journal, 41(8), 789-795.
3.
Adams, R., & Jacobs, H. (2023). The long-term effects of COVID-19 on child
development. Medical Science Monitor, 29, 2156-2165.
4.
World Health Organization (WHO). (2021). Guidance for pediatric management of
COVID-19. WHO Technical Reports.
5.
Mitchell, R., & Taylor, L. (2022). Pneumonia after COVID-19: A study of pediatric
cases. Journal of Clinical Pediatrics, 58(1), 23-31.
6.
Zhang, L., & Li, T. (2023). Psychological impact of COVID-19 on children: A
review of current literature. Child and Adolescent Psychiatry, 31(2), 123-130.
